Hiroshi Ariyama

4PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).

Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi

|Mar 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.

Michitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige

|Sep 02, 2022
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.

Tomoyasu Yoshihiro, Hiroshi Ariyama, Kyoko Yamaguchi

|Jun 06, 2022
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.

Kyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama

Pageof 1